The Searle Company Limited Pakistan — Biomedical Watch V2

Traitements2programmes

Essais1liés

Publications0liées

SourceDBlocale

Traitements

2

Molécule	Indication / population	Phase	Objectif	Pays	Résultat
Syrup HydryllinA cough is one of the most common medical complaints accounting for as many as 30 million clinical visits per year. It is the single most prevalent symptom on presentation to a physician's office. Up to 40% of these complaints result in a referral to a pulmonologist. Although, the cough is an essential defense mechanism, still, chronic cough may cause significant morbidity and substantially affect the quality of life and psychosocial wellbeing.	SEP	À vérifier	Traitement symptomatique	Pakistan	À vérifier
Syrup HydryllinA cough is one of the most common medical complaints accounting for as many as 30 million clinical visits per year. It is the single most prevalent symptom on presentation to a physician's office. Up to 40% of these complaints result in a referral to a pulmonologist. Although, the cough is an essential defense mechanism, still, chronic cough may cause significant morbidity and substantially affect the quality of life and psychosocial wellbeing.	SEP	À vérifier	Traitement symptomatique	Pakistan	À vérifier

Essais cliniques

1

Molécule	Indication / population	Phase	NCT	Titre	Statut
Syrup Hydryllin	SEP	À vérifier	NCT05129761	HYD-EFFECT — Clinical Response of Syrup Hydryllin® in Pakistani Subjects With Cough in Routine Practice	COMPLETED

Publications

0

Molécule	Indication / population	Titre	Journal	Date
Aucune publication.